These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35789341)

  • 21. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas.
    Li J; Zhang Y; Qu Z; Ding R; Yin X
    Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Qu S; Liu J; Wang H
    Front Immunol; 2021; 12():648416. PubMed ID: 33889156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas.
    Li J; Wang J; Ding Y; Zhao J; Wang W
    BMC Cancer; 2022 Apr; 22(1):466. PubMed ID: 35484511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic Value of
    Xu X; Zhong Z; Shao Y; Yi Y
    Front Genet; 2021; 12():679097. PubMed ID: 34220951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-Cancer Analysis of the Prognostic and Immunological Role of SMG5: A Biomarker for Cancers.
    Yang L; Wei J; Ma X; Cheng R; Zhang H; Jin T
    Oncology; 2024; 102(2):168-182. PubMed ID: 37699361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
    Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
    Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Hu Z; Qu S
    Front Immunol; 2021; 12():683572. PubMed ID: 34267752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma.
    Wang D; Sun H; Li X; Wang G; Yan G; Ren H; Hou B
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma.
    Shi H; Song Y; Song Z; Huang C
    PLoS One; 2021; 16(1):e0245524. PubMed ID: 33465115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment.
    Zhu H; Hu X; Gu L; Jian Z; Li L; Hu S; Qiu S; Xiong X
    Front Genet; 2021; 12():759953. PubMed ID: 34721547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 36. Development and validation of a leukocyte-associated immunoglobulin-like receptor-1 prognostic signature for lower-grade gliomas.
    Fang Z; Lin L; Tu Z; Zhu X; Li J; Luo P; Huang K; Wu L
    Cancer Med; 2023 Jan; 12(1):712-732. PubMed ID: 35702880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma.
    Wang H; Wang X; Xu L; Zhang J
    Cancer Med; 2023 Feb; 12(4):4951-4967. PubMed ID: 36043552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ESCO2 or its methylation on the prognosis, clinical characteristics, immune microenvironment, and pathogenesis of low-grade glioma.
    Liu Z; Cheng X; Pang B; Wang S; Liu B; Cao C; Qian R; Liang W; Zhu Y; Li P; Gao Y
    Int Immunopharmacol; 2022 Mar; 104():108399. PubMed ID: 35008004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltration.
    Wu S; Miao K; Wang L; Ma Y; Wu X
    Med Oncol; 2022 Jan; 39(2):27. PubMed ID: 35018510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.